Skip to content
ClinCalc Pro
Menu
Emergency Medicine General Medicine Strong — NICE NG84 endorsed

Centor Score for Strep Pharyngitis

Estimates probability of Group A Streptococcal pharyngitis to guide testing and antibiotic use (derived in adults; Centor 1981).

How to use & interpret

The Centor score (and the age-adjusted McIsaac modification) estimates the likelihood that a sore throat is due to group A streptococcus, to target testing and antibiotics. Points are given for tonsillar exudate, tender anterior cervical nodes, fever, and absence of cough (McIsaac adjusts for age).

Low scores make strep unlikely and support no antibiotic; higher scores raise the probability and may justify testing or, depending on local policy, empirical antibiotics. In UK primary care the FeverPAIN score is an alternative recommended by NICE. Both are guides to support antibiotic stewardship, not a substitute for clinical assessment.

Score interpretation

Low Risk 0–1

Centor 0–1: probability of GAS 2.5–6.5% (Centor 1981).

→ No antibiotic; self-care and safety-netting advice (NICE NG84).

Moderate Risk 2–3

Centor 2–3: probability of GAS 15–32%.

→ Centor 2: no antibiotic. Centor 3: consider an immediate or back-up antibiotic prescription (NICE NG84).

High Risk 4

Centor 4: probability of GAS 56%.

→ Empirical antibiotic treatment (adults: penicillin V or amoxicillin 500mg TDS 10 days) or test and treat. Children: use a children's formulary.

Interpretation bands for the Centor. Apply clinical judgement and local guidance.

Frequently asked questions

Centor or FeverPAIN?

Both are validated; NICE NG84 references FeverPAIN and Centor. FeverPAIN was derived in UK primary care and tends to recommend fewer antibiotics. Use whichever your local guidance specifies, consistently.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.